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Small-colony variants (SCVs) of Staphylococcus aureus cause persistent and relapsing infections.
Relatively little is known regarding infections caused by SCVs of coagulase-negative staphylococci.
We report two cases of pacemaker electrode infections due to SCVs of Staphylococcus epidermidis
and Staphylococcus capitis. Sequence analysis of a portion of the 16S rRNA gene (16S rDNA)
confirmed the identity of the staphylococcal species as S. capitis and S. epidermidis. Isolates from
cultures of blood obtained over at least a 2-week interval were compared by pulsed-field gel
electrophoresis and found to be clonal even though the colony morphology was very different.
Analysis for auxotrophism revealed hemin dependencies for all isolated SCVs. The two cases have
several clinical and laboratory characteristics (which are also seen with S. aureus SCV infections)
and strongly suggest that SCVs of coagulase-negative staphylococci must be actively sought, because
they grow very slowly and can be easily missed.
Although Staphylococcus aureus small-colony variants (SCVs)
have been recognized for many years, the connection of this
phenotype with persistent infections has only recently been appre-
ciated [1, 2]. They have been reported to produce relapsing infec-
tions in bone, heart valves, lung, and soft tissues [1]. The signif-
icance of these variants particularly in patients with chronic
osteomyelitis and patients with cystic fibrosis has been demon-
strated in prospective studies [3, 4]. Herein, we report two cases of
bloodstream infections due to SCVs of coagulase-negative staphy-
lococci (CoNS) following endocardial pacemaker electrode im-
plantation and compare their clinical and laboratory characteristics
with those of infections caused by S. aureus SCVs.
Diagnostic Methods
Identification. CoNS were identified on the basis of a va-
riety of conventional phenotypic characteristics, the biochem-
ical profile (which was determined by using the API System
[ATB32 Staph Strips, 26 tests; and API Staph Strips, 19 tests;
bioMe´rieux, Marcy l’Etoile, France] after 48 hours of incuba-
tion at 37°C), and the absence of the S. aureus–specific nuc
gene [5]. SCVs were identified as slow-growing, nonpig-
mented, nonhemolytic pinpoint colonies that were observed
after 48–72 hours of incubation on rabbit blood agar [3, 4].
Very small colonies on Columbia agar were suspected as SCVs
if they grew nearly normally on Schaedler’s agar (with CO2 or
anaerobically) [4].
Auxotrophism studies. Auxotrophy for hemin (Unipath,
Basingstoke, United Kingdom) was tested by using standard
disks, and autotrophy for thymidine (Fluka Chemie, Buchs,
Switzerland) or menadione (Sigma Aldrich Chemie, Deisen-
hofen, Germany) was tested by impregnating disks with 15 mL
of thymidine or menadione at 100 mg/mL. Test isolates were
inoculated on chemically defined medium as previously de-
scribed [3, 4].
Analysis of 16S rDNA. Extraction of DNA and amplifica-
tion of 1 kilobase of the bacterial 16S rDNA were carried out
with use of primers 285 and 261 as previously described [6].
Briefly, DNA was prepared from single colonies of both the
species Staphylococcus epidermidis and Staphylococcus capitis
grown on blood agar and disrupted mechanically. A 300-bp
portion of the amplified DNA was sequenced by direct se-
quencing with the primer 285 and the internal primer 244 [6]
by using fluorescent dideoxy-dye terminators on an automated
DNA sequencer (ABI 373A; Perkin-Elmer, Rotkreuz, Switzer-
land). Results were controlled for sequencing errors and com-
pared with NCBI GenBank entries by using a BLAST algo-
rithm [7].
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Molecular typing. To examine the clonality of phenotypi-
cally normal CoNS and SCV isolates, we analyzed these strains
with pulsed-field gel electrophoresis as previously described [4].
SmaI digests of total bacterial DNA were resolved, and strains
were considered clonal if less than two bands varied on a gel.
Case Reports
Case 1. A 62-year-old man presented for evaluation of a
3-month history of relapsing episodes of fever and chills.
History revealed pacemaker placement for bradycardia 4
months earlier. Physical examination was unremarkable except
for a soft decrescendo aortic murmur. Laboratory examinations
showed mild anemia, elevated C-reactive protein (CRP) level,
and elevated erythrocyte sedimentation rate (ESR), but the
WBC count and differential cell counts were normal. Trans-
esophageal echocardiography and CT of the chest and abdo-
men were unremarkable. Initial blood cultures yielded CoNS,
which were interpreted as contaminants and not further differ-
entiated. However, eight additional cultures of blood obtained
over the following 17 days were positive for S. epidermidis.
Visible growth (very small colonies) on a subculture plate
started after 48 hours of incubation at 37°C. The organisms
isolated after 48–72 hours were so heterogeneous in their
colonial morphology that polymicrobial infection was sus-
pected. Biochemical testing with API Staph Strips and conven-
tional macrotube testing were not possible (although catalase
positivity was found in all seven isolates) because limited
growth over 48 hours was not sufficient enough to provide
positive test results in the reaction vials. Therefore, two ap-
proaches were used to identify the positive blood cultures.
First, by analyzing the 16S rDNA, the sequences of the ampli-
cons over 250 nucleotides were found to be identical to previ-
ously reported sequences of S. epidermidis (accession no.
L37605). Second, SmaI digests of the whole bacterial genome
of all isolates were typed by pulsed-field gel electrophoresis
and were found to be clonal, despite large differences in their
colony phenotype. Thus, the seven isolates were the same
species and clonal.
Analysis of auxotrophism revealed that the SCVs were hemin
auxotrophic. The organisms were susceptible to ceftriaxone, and
because of penicillin allergy, therapy with ceftriaxone was initi-
ated for 6 weeks. The pacemaker was not removed because fever
quickly resolved, and the CRP level and ESR returned to normal.
A follow-up transesophageal echocardiogram, total-body CT, and
bone scans were also unremarkable. Although the source of in-
fection remained unproved, the number of positive blood cultures,
the temporal relationship of the onset of fever with the placement
of the pacemaker, and the absence of other foreign bodies sug-
gested that the pacemaker was the most likely focus of infection.
Seven months after stopping antibiotic therapy, no signs of infec-
tion were observed.
Case 2. A 64-year-old man presented for evaluation of a
2-week history of recurrent fever (temperature up to 40°C) and
chills following a tooth extraction 10 days before the initial
onset of symptoms. The patient had a pacemaker placed 3 years
ago for bradycardia due to sick sinus syndrome. Laboratory
examinations showed severe anemia and an elevated WBC
count, CRP level, and ESR. While a chest roentgenograph and
an abdominal sonograph were unremarkable, a transesophageal
echocardiogram indicated a 2.5-cm vegetation on the trans-
venous endocardial pacemaker electrode. There was no evi-
dence of infection of the skin and soft tissue overlying the
implanted generator.
Four cultures of blood obtained over a 2-week period, which
were recognized as positive after 3 days of incubation of the
subculture plates, yielded S. capitis. Sequence analysis of a
portion of the 16S rRNA gene (16S rDNA) confirmed the
identity of the isolates as S. capitis (accession no. L37599). The
isolates, which grew mostly as pinpoint colonies, proved to be
hemin-auxotrophic SCVs. Upon subculture from the solid me-
dium, some colonies grew rapidly. All isolates were compared
by pulsed-field gel electrophoresis and found to be clonal even
though the colony morphology was very different.
Oxacillin and gentamicin treatment was started, and fever
promptly resolved. Because the vegetations could still be de-
tected 5 weeks after initiation of antibiotic therapy, the pace-
maker was removed. The electrode of the pacemaker was
cultured, and pinpoint colonies grew after 72 hours of incuba-
tion. In a following subculture, these organisms did not grow,
making further differentiation impossible. After a further
2-week course of the same antibiotic regimen, the patient
remained afebrile, and there was no recurrence in the subse-
quent 10 months.
Discussion
SCVs are a naturally occurring subpopulation that grow
slowly and produce small colonies (hence, their name).
S. aureus SCVs were first described .80 years ago, and a
number of studies support a pathogenic role for SCVs in
diseases [1–4]. S. aureus SCVs have been reported to produce
persistent and often recurrent infections and have a number of
characteristics that are atypical for S. aureus, including reduced
coagulase production, failure to ferment mannitol, and in-
creased resistance to aminoglycosides and cell wall–active
antibiotics [1, 2]. Biochemical characterization of most clinical
SCVs reveals defects in electron transport. Clinical and
laboratory-generated SCVs are frequently auxotrophic for
menadione and hemin, two compounds required in the biosyn-
thesis of the electron transport chain components menaquinone
and cytochrome, respectively [1, 3, 4, 8]. In addition, S. aureus
SCVs have been found to persist inside of cultured endothelial
cells, probably because these variants produce very little
a-toxin [8, 9]. The intracellular location may shield SCVs from
the host immune response and decreases exposure to antibiotics
[4, 8, 9].
Compared with S. aureus SCVs, very little is known regard-
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ing infections caused by SCVs of CoNS. There are only two
well-described cases of infection due to phenotypic variants of
CoNS; however, strains were not characterized as slow-
growing electron transport–deficient SCVs regarding their auxo-
trophisms [10, 11]. Infections caused by SCVs of S. capitis
have not yet been reported. The two cases reported here have
several characteristic laboratory features, which have also been
seen with S. aureus SCV infections. First, the organisms grew
very slowly and could have been easily missed if the blood
subcultures were examined only for 48 hours, particularly
when large-colony forms were also present. Second, SCVs
were difficult to identify because of their slow and atypical
biochemical reactions. They had changed biochemical charac-
teristics, such as reduced lactose and turanose fermentation
and/or no nitrate reduction. In a previous study in which a
stable genetically defined mutant with a SCV phenotype was
used, the absence of sugar alcohol (e.g., mannitol) fermentation
was explained by interrupted electron transport [8].
Third, the presence of heterogeneous colony forms initially
suggested a mixed infection; however, all of the isolates proved
to be from the same species, and the subpopulations were also
from the same clone. Fourth, all SCVs isolated from these
patients were hemin auxotrophs. Fifth, SCVs grow more rap-
idly in the presence of CO2 and on rich medium, such as
Schaedler’s agar (which contains hemin). Hence, these SCVs
can be construed as anaerobic organisms since these conditions
are often used for anaerobic blood cultures. Because oxygen
does not enhance the growth of electron transport–deficient
SCVs, their growth in an anaerobic chamber on Schaedler’s
agar can make laboratory personnel believe that anaerobes are
present [1].
Thus, SCVs of CoNS are similar to S. aureus SCVs in many
ways. However, differences regarding antibiotic susceptibili-
ties, which were observed when normal phenotypes and SCVs
of S. aureus were compared, were not seen in the cases pre-
sented. The SCVs of CoNS from both patients were susceptible
to the antibiotics tested, but testing was extended to 48–72
hours to allow sufficient growth of the controls. Finally, be-
cause of the large differences in colony morphology and the
slow growth of these SCVs of CoNS, molecular techniques
may be required for identification.
The clinical presentations of our two patients are of interest
in view of the rather benign symptoms of endovascular infec-
tions. These benign symptoms are typical for infections caused
by S. aureus SCVs because the ability of the SCV strain to lyse
mammalian cells and to produce toxins is less than that of the
rapidly growing parent strain [2, 8, 9]. Both patients responded
well to antibiotic therapy with no recurrences of signs or
symptoms, although deposits on the pacemaker wire in one
case were still detectable after treatment with antibiotics. This
course is somewhat different than that seen with both normal
phenotypes and SCVs of S. aureus, where breakthrough bac-
teremia during therapy and recurrences after termination of
antibiotic therapy are common. This course, however, is con-
sistent with the expected responses to antibiotic therapy when
the efficacy of antibiotic treatment alone for S. aureus pros-
thetic device infections is compared with that of antibiotic
treatment alone for prosthetic device infections due to CoNS.
Specifically, S. aureus prosthetic device infections are very
rarely cleared without removing the device, whereas
coagulase-negative organisms may be clinically eradicated
about one-half of the time [12].
Therefore, although some differences are seen, many of the
clinical and laboratory characteristics of S. aureus SCVs are
also found with SCVs of CoNS. Thus, SCVs of CoNS must be
actively sought, because they can be easily missed due to their
slow growth and may cause serious infections.
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